{
    "title": "Pfizer to spend $11.6B on migraine treatment maker Biohaven",
    "url": "https://www.dailymail.co.uk/wires/ap/article-10801201/Pfizer-spend-11-6B-migraine-treatment-maker-Biohaven.html",
    "date": "2022-05-10",
    "keywords": [
        "pfizer",
        "biohaven",
        "cash",
        "spray",
        "treatment",
        "development",
        "company",
        "york",
        "vaccine",
        "drug",
        "tuesday",
        "migraine",
        "quarter",
        "comirnaty",
        "year",
        "deal",
        "odt",
        "covid19",
        "maker",
        "portion",
        "share",
        "revenue",
        "portfolio",
        "trading",
        "influx",
        "venture",
        "area",
        "cancer",
        "hand",
        "developer",
        "inc",
        "pill",
        "virus",
        "pifzer",
        "biontech",
        "loss",
        "patent",
        "protection",
        "decade",
        "eliquis",
        "blood",
        "prevnar",
        "pneumonia",
        "man",
        "walks",
        "drugmaker",
        "nasal",
        "ap",
        "photomark",
        "lennihan",
        "come",
        "business",
        "step",
        "direction",
        "tablet",
        "vydura",
        "union",
        "product",
        "marketing",
        "muscle",
        "zavegepant",
        "track",
        "acceptance",
        "gel",
        "version",
        "giant",
        "acquirer",
        "part",
        "presence",
        "care",
        "position",
        "need",
        "growth",
        "analyst",
        "dr",
        "vamil",
        "divan",
        "research",
        "note",
        "pipeline",
        "name",
        "sale",
        "stake",
        "ltd",
        "connecticut",
        "midday",
        "stock",
        "tom",
        "murphy",
        "twitter",
        "httpstwittercomthpmurphy",
        "story",
        "agreement"
    ],
    "category": [
        "wires",
        "ap"
    ]
}